Myeloma Paper of the Day, August 28th, Suggested by Robert Orlowski
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Pre-treatment with iberdomide and dex in Vk*MYC mouse model reshapes bone marrow T cell compartment, promotes infiltration of naive T cells, and generates 100% response rates and long survival in subjects with high tumor burden.”
Title: An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden
Authors: Erin W Meermeier, Kirsten Pfeffer, Caleb K Stein, Meaghen Sharik, Megan Tien Du, Yuliza Tafoya Alvarado, Chang-Xin Shi, Yuan Xiao Zhu, Peter Leif Bergsagel, Marta Chesi
You can read the Full Article on Blood.
You can find more posts featuring Robert Orlowski on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023